Acidic nuclear phosphoprotein 32kDa (ANP32)B-deficient mouse reveals a hierarchy of ANP32 importance in mammalian development

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 25, 2011, Pages 10243-10248

  Reilly, Patrick T ^a   Afzal, Samia ^b,c   Gorrini, Chiara ^b   Lui, Koren ^b   Bukhman, Yury V ^b,e   Wakeham, Andrew ^b   Haight, Jillian ^b   Ling, Teo Wei ^a   Cheung, Carol C ^b   Elia, Andrew J ^b   Turner, Patricia V ^d   Mak, Tak Wah ^a,b  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF GUELPH   (Canada)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Cell growth; Mouse embryogenesis; Premature aging

Indexed keywords

ACIDIC NUCLEAR PHOSPHOPROTEIN 32 A; ACIDIC NUCLEAR PHOSPHOPROTEIN 32 B; ACIDIC NUCLEAR PHOSPHOPROTEIN 32 E; PHOSPHOPROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BREAST CANCER; CELL PROLIFERATION; CELL VIABILITY; DISEASE MARKER; EMBRYO DEVELOPMENT; FEMALE; FIBROBLAST; GENE TARGETING; LIFESPAN; MALE; MOUSE; NEWBORN; NONHUMAN; PERINATAL DEATH; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELLS, CULTURED; EMBRYO, MAMMALIAN; FEMALE; FIBROBLASTS; GENE TARGETING; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; RNA, MESSENGER; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

MAMMALIA; MURINAE; MUS;

EID: 79960003270     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1106211108     Document Type: Article

References (45)

1. Santa-Coloma TA (2003) Anp32e (Cpd1) and related protein phosphatase 2 inhibitors. Cerebellum 2:310-320.
2. Huyton T, Wolberger C (2007) The crystal structure of the tumor suppressor protein pp32 (Anp32a): Structural insights into Anp32 family of proteins. Protein Sci 16:1308-1315. (Pubitemid 46984865)
3. Matilla A, Radrizzani M (2005) The Anp32 family of proteins containing leucine-rich repeats. Cerebellum 4:7-18. (Pubitemid 40592803)
4. Anisimov SV, et al. (2002) SAGE identification of gene transcripts with profiles unique to pluripotent mouse R1 embryonic stem cells. Genomics 79:169-176.
5. Brody JR, et al. (2004) pp32 reduction induces differentiation of TSU-Pr1 cells. Am J Pathol 164:273-283. (Pubitemid 38364611)
6. Kular RK, Cvetanovic M, Siferd S, Kini AR, Opal P (2009) Neuronal differentiation is regulated by leucine-rich acidic nuclear protein (LANP), a member of the inhibitor of histone acetyltransferase complex. J Biol Chem 284:7783-7792.
7. Puente LG, Carrière JF, Kelly JF, Megeney LA (2004) Comparative analysis of phosphoprotein-enriched myocyte proteomes reveals widespread alterations during differentiation. FEBS Lett 574:138-144. (Pubitemid 39200909)
8. Adegbola O, Pasternack GR (2005) Phosphorylated retinoblastoma protein complexes with pp32 and inhibits pp32-mediated apoptosis. J Biol Chem 280:15497-15502. (Pubitemid 40616664)
9. Hoffarth S, et al. (2008) pp32/PHAPI determines the apoptosis response of non-small-cell lung cancer. Cell Death Differ 15:161-170. (Pubitemid 350286184)
10. Jiang X, et al. (2003) Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Science 299:223-226. (Pubitemid 36125203)
11. Mazroui R, et al. (2008) Caspase-mediated cleavage of HuR in the cytoplasm contributes to pp32/PHAP-I regulation of apoptosis. J Cell Biol 180:113-127.
12. Pan W, et al. (2009) PHAPI/pp32 suppresses tumorigenesis by stimulating apoptosis. J Biol Chem 284:6946-6954.
13. Schafer ZT, et al. (2006) Enhanced sensitivity to cytochrome c-induced apoptosis mediated by PHAPI in breast cancer cells. Cancer Res 66:2210-2218.
14. Sun W, et al. (2006) Proliferation related acidic leucine-rich protein PAL31 functions as a caspase-3 inhibitor. Biochem Biophys Res Commun 342:817-823. (Pubitemid 43320471)
15. Amasaki H, et al. (2003) Distributional changes of BrdU, PCNA, E2F1 and PAL31 molecules in developing murine palatal rugae. Ann Anat 185:517-523. (Pubitemid 37540823)
16. Fukukawa C, Tanuma N, Okada T, Kikuchi K, Shima H (2005) pp32/I-1(PP2A) negatively regulates the Raf-1/MEK/ERK pathway. Cancer Lett 226:155-160. (Pubitemid 41039083)
17. Sun W, et al. (2001) PAL31, a nuclear protein required for progression to the S phase. Biochem Biophys Res Commun 280:1048-1054. (Pubitemid 32924446)
18. Costanzo RV, et al. (2006) Anp32e/Cpd1 regulates protein phosphatase 2A activity at synapses during synaptogenesis. Eur J Neurosci 23:309-324.
19. Li M, Makkinje A, Damuni Z (1996) Molecular identification of I1PP2A, a novel potent heat-stable inhibitor protein of protein phosphatase 2A. Biochemistry 35:6998-7002.
20. Radrizzani M, et al. (2001) Differential expression of CPD1 during postnatal development in the mouse cerebellum. Brain Res 907:162-174. (Pubitemid 32595526)
21. Hill MM, Adrain C, Duriez PJ, Creagh EM, Martin SJ (2004) Analysis of the composition, assembly kinetics and activity of native Apaf-1 apoptosomes. EMBO J 23:2134-2145. (Pubitemid 38737740)
22. Fries B, et al. (2007) Analysis of nucleocytoplasmic trafficking of the HuR ligand APRIL and its influence on CD83 expression. J Biol Chem 282:4504-4515. (Pubitemid 47100928)
23. Gallouzi IE, Brennan CM, Steitz JA (2001) Protein ligands mediate the CRM1-dependent export of HuR in response to heat shock. RNA 7:1348-1361, and partial retraction (2003) 9:1410.
24. Itin C, Ulitzur N, Mühlbauer B, Pfeffer SR (1999) Mapmodulin, cytoplasmic dynein, and microtubules enhance the transport of mannose 6-phosphate receptors from endosomes to the trans-golgi network. Mol Biol Cell 10:2191-2197. (Pubitemid 29343128)
25. Opal P, et al. (2003) Mapmodulin/leucine-rich acidic nuclear protein binds the light chain of microtubule-associated protein 1B and modulates neuritogenesis. J Biol Chem 278:34691-34699. (Pubitemid 37553319)
26. Kutney SN, Hong R, Macfarlan T, Chakravarti D (2004) A signaling role of histonebinding proteins and INHAT subunits pp32 and Set/TAF-Ibeta in integrating chromatin hypoacetylation and transcriptional repression. J Biol Chem 279:30850-30855. (Pubitemid 38938020)
27. Schneider R, Bannister AJ, Weise C, Kouzarides T (2004) Direct binding of INHAT to H3 tails disrupted by modifications. J Biol Chem 279:23859-23862. (Pubitemid 38725241)
28. Seo SB, et al. (2002) Regulation of histone acetylation and transcription by nuclear protein pp32, a subunit of the INHAT complex. J Biol Chem 277:14005-14010.
29. Tochio N, et al. (2010) Solution structure of histone chaperone ANP32B: Interaction with core histones H3-H4 through its acidic concave domain. J Mol Biol 401:97-114.
30. Cvetanovic M, et al. (2007) The role of LANP and ataxin 1 in E4F-mediated transcriptional repression. EMBO Rep 8:671-677. (Pubitemid 47029474)
31. Loven MA, et al. (2004) A novel estrogen receptor alpha-associated protein alters receptor-deoxyribonucleic acid interactions and represses receptor-mediated transcription. Mol Endocrinol 18:2649-2659. (Pubitemid 39482055)
32. Munemasa Y, et al. (2008) Promoter region-specific histone incorporation by the novel histone chaperone ANP32B and DNA-binding factor KLF5. Mol Cell Biol 28:1171-1181. (Pubitemid 351160072)
33. Shen SM, et al. (2010) Downregulation of ANP32B, a novel substrate of caspase-3, enhances caspase-3 activation and apoptosis induction in myeloid leukemic cells. Carcinogenesis 31:419-426.
34. Opal P, et al. (2004) Generation and characterization of LANP/pp32 null mice. Mol Cell Biol 24:3140-3149. (Pubitemid 38452060)
35. Reilly PT, et al. (2010) Generation and characterization of the Anp32e-deficient mouse. PLoS ONE 5:e13597.
36. Buszczak M, et al. (2007) The carnegie protein trap library: A versatile tool for Drosophila developmental studies. Genetics 175:1505-1531. (Pubitemid 46798248)
37. van de Vijver MJ, et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999-2009.
38. Hu Z, et al. (2006) The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 7:96.
39. Miller LD, et al. (2005) An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci USA 102:13550-13555. (Pubitemid 41420886)
40. Zippo A, De Robertis A, Bardelli M, Galvagni F, Oliviero S (2004) Identification of Flk-1 target genes in vasculogenesis: Pim-1 is required for endothelial and mural cell differentiation in vitro. Blood 103:4536-4544. (Pubitemid 38745981)
41. Okada H, et al. (2002) Generation and characterization of Smac/DIABLO-deficient mice. Mol Cell Biol 22:3509-3517. (Pubitemid 34453989)
42. Ruland J, et al. (2001) p53 accumulation, defective cell proliferation, and early embryonic lethality in mice lacking tsg101. Proc Natl Acad Sci USA 98:1859-1864. (Pubitemid 32165588)
43. Lin AW, et al. (1998) Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev 12:3008-3019. (Pubitemid 28469303)
44. Zaugg K, et al. (2007) Cross-talk between Chk1 and Chk2 in double-mutant thymocytes. Proc Natl Acad Sci USA 104:3805-3810, and correction (2007) 104: 8196.
45. Dufner A, et al. (2008) CARD6 is interferon inducible but not involved in nucleotide-binding oligomerization domain protein signaling leading to NF-kappaB activation. Mol Cell Biol 28:1541-1552.